Skip to main content
Contact +1 (919) 234-1277

🚀 Special Offer🚀Get 25% off on your bioreagent online order (except Micelles and Nanodiscs), with the code: PROTEOSHOP25

📢 New ! Accelerate your Antibody Development with Ready-to-use Stable Cell Pools

Explore Now
Nycodenz AG® Nycodenz AG® XtenCHO ™ Race Starter kit XtenCHO ™ Race Starter kit
View all Products

Human VEGF Recombinant Protein

Reference:
Product Image
SDS-PAGE for Human VEGF Recombinant Protein
Product Image
SDS-PAGE for Human VEGF Recombinant Protein
size

100ug, 50ug
Brand

ProteoGenix
Product type

Recombinant Proteins
Host Species

Escherichia coli (E. coli)
Applications

Elisa, WB
Tags:
Specification
Documents
QC & Validation Data1
Publications
Reviews
Product nameHuman VEGF Recombinant Protein
Uniprot IDP15692
Uniprot linkhttp://www.uniprot.org/uniprot/P15692
Origin speciesHomo sapiens (Human)
Expression systemProkaryotic expression
SequenceMAHNHRHKHKLDDDDKAPMAEGGGQNHHEVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKKDR
Molecular weight14,65 kDa
Protein delivered with Tag?Yes
Purity estimated70%
BufferPBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol
FormFrozen
Delivery conditionDry Ice
Delivery lead time in business days3-5 days if in stock; 3-5 weeks if production needed
Storage condition4°C for short term (1 week), -20°C or -80°C for long term (avoid freezing/thawing cycles; addition of 20-40% glycerol improves cryoprotection)
BrandProteoGenix
Host speciesEscherichia coli (E.coli)
Fragment TypePartial
Protein AccessionAAH65522.2
Spec:Entrez GeneID7422
Spec:NCBI Gene AliasesMVCD1, VPF, VEGF
Spec:SwissProtIDP15692
NCBI ReferenceAAH65522.2
Aliases /SynonymsVEGF, VEGFA protein, Vascular endothelial Growth Factor proteins A, VEGF-A, Vascular permeability factor, VPF, VEGFA
ReferencePX-P1060
NoteFor research use only.
Datasheet Download
MSDS Download

SDS-PAGE for Human VEGF Recombinant Protein

Human VEGF Recombinant Protein, on SDS-PAGE under reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.

Publication

  • 1: Burmeister K, Quagliata L, Andreozzi M, Eppenberger-Castori S, Matter MS,_x000D_ Perrina V, Grobholz R, Jochum W, Horber D, Moosmann P, Lehmann F, Köberle D, Ng_x000D_ CK, Piscuoglio S, Tornillo L, Terracciano LM. Vascular endothelial Growth Factor proteins _x000D_ A amplification in colorectal cancer is associated with reduced M1 and M2_x000D_ macrophages and diminished PD-1-expressing lymphocytes. PLoS One. 2017 Apr_x000D_ 12;12(4):e0175563. doi: 10.1371/journal.pone.0175563. eCollection 2017. PubMed_x000D_ PMID: 28403223; PubMed Central PMCID: PMC5389821.
    • _x000D_ _x000D_ _x000D_
  • 2: Yin J, Shen L, Ji M, Wu Y, Cai S, Chen J, Yao Z, Ge J. Inverse Relationship_x000D_ between Serum VEGF Levels and Late In-Stent Restenosis of Drug-Eluting Stents._x000D_ Biomed Res Int. 2017;2017:8730271. doi: 10.1155/2017/8730271. Epub 2017 Mar 8._x000D_ PubMed PMID: 28373989; PubMed Central PMCID: PMC5360953.
    • _x000D_ _x000D_ _x000D_
  • 3: Ruffolo C, Toffolatti L, Canal F, Kotsafti A, Pagura G, Pozza A, Campo_x000D_ Dell'Orto M, Ferrara F, Massani M, Dei Tos AP, Castoro C, Bassi N, Scarpa M._x000D_ Colorectal polypoid lesions and expression of vascular endothelial Growth Factor proteins _x000D_ in a consecutive series of endoscopic and surgical patients. Tumour Biol. 2017_x000D_ Mar;39(3):1010428317692263. doi: 10.1177/1010428317692263. PubMed PMID: 28347226.
    • _x000D_ _x000D_ _x000D_
  • 4: Naykoo NA, Dil-Afroze, Rasool R, Shah S, Ahangar AG, Bhat IA, Qasim I, Siddiqi_x000D_ MA, Shah ZA. Single nucleotide polymorphisms, haplotype association and tumour_x000D_ expression of the vascular endothelial Growth Factor proteins (VEGF) gene with lung_x000D_ carcinoma. Gene. 2017 Apr 15;608:95-102. doi: 10.1016/j.gene.2017.01.007. Epub_x000D_ 2017 Jan 23. PubMed PMID: 28122267.
    • _x000D_ _x000D_ _x000D_
  • 5: Zhuo Y, Zeng Q, Zhang P, Li G, Xie Q, Cheng Y. VEGF Promoter Polymorphism_x000D_ Confers an Increased Risk of Pulmonary Arterial Hypertension in a Chinese_x000D_ Population. Yonsei Med J. 2017 Mar;58(2):305-311. doi: 10.3349/ymj.2017.58.2.305._x000D_ PubMed PMID: 28120560; PubMed Central PMCID: PMC5290009.
    • _x000D_ _x000D_ _x000D_
  • 6: Dang YZ, Zhang Y, Li JP, Hu J, Li WW, Li P, Wei LC, Shi M. High VEGFR1/2_x000D_ expression levels are predictors of poor survival in patients with cervical_x000D_ cancer. Medicine (Baltimore). 2017 Jan;96(1):e5772. doi:_x000D_ 10.1097/MD.0000000000005772. PubMed PMID: 28072723; PubMed Central PMCID:_x000D_ PMC5228683.
    • _x000D_ _x000D_ _x000D_
  • 7: Martynova EV, Valiullina AH, Gusev OA, Davidyuk YN, Garanina EE, Shakirova VG,_x000D_ Khaertynova I, Anokhin VA, Rizvanov AA, Khaiboullina SF. High Triglycerides Are_x000D_ Associated with Low Thrombocyte Counts and High VEGF in Nephropathia Epidemica. J_x000D_ Immunol Res. 2016;2016:8528270. doi: 10.1155/2016/8528270. Epub 2016 Dec 5._x000D_ PubMed PMID: 28053993; PubMed Central PMCID: PMC5178363.
    • _x000D_ _x000D_ _x000D_
  • 8: López-Cancio E, Ricciardi AC, Sobrino T, Cortés J, de la Ossa NP, Millán M,_x000D_ Hernández-Pérez M, Gomis M, Dorado L, Muñoz-Narbona L, Campos F, Arenillas JF,_x000D_ Dávalos A. Reported Prestroke Physical Activity Is Associated with Vascular_x000D_ Endothelial Growth Factor proteins Expression and Good Outcomes after Stroke. J Stroke_x000D_ Cerebrovasc Dis. 2017 Feb;26(2):425-430. doi:_x000D_ 10.1016/j.jstrokecerebrovasdis.2016.10.004. Epub 2016 Oct 28. PubMed PMID:_x000D_ 28029607.
    • _x000D_ _x000D_ _x000D_
  • 9: Ghazizadeh H, Fazilati M, Pasdar A, Avan A, Tayefi M, Ghasemi F, Mehramiz M,_x000D_ Mirhafez SR, Ferns GA, Azimi-Nezhad M, Ghayour-Mobarhan M. Association of a_x000D_ Vascular Endothelial Growth Factor proteins genetic variant with Serum VEGF level in_x000D_ subjects with Metabolic Syndrome. Gene. 2017 Jan 20;598:27-31. doi:_x000D_ 10.1016/j.gene.2016.10.034. Epub 2016 Oct 27. PubMed PMID: 27984191.
    • _x000D_ _x000D_ _x000D_
  • 10: Barchitta M, Maugeri A. Association between Vascular Endothelial Growth_x000D_ Factor Polymorphisms and Age-Related Macular Degeneration: An Updated_x000D_ Meta-Analysis. Dis Markers. 2016;2016:8486406. doi: 10.1155/2016/8486406. Epub_x000D_ 2016 Nov 23. PubMed PMID: 27999450; PubMed Central PMCID: PMC5141552.
    • _x000D_ _x000D_ _x000D_
  • 11: Li J, Sun K, Chen Z, Shi J, Zhou D, Xie G. A fluorescence biosensor for VEGF _x000D_ detection based on DNA assembly structure switching and isothermal amplification._x000D_ Biosens Bioelectron. 2017 Mar 15;89(Pt 2):964-969. doi:_x000D_ 10.1016/j.bios.2016.09.078. Epub 2016 Sep 30. PubMed PMID: 27816590.
    • _x000D_ _x000D_ _x000D_
  • 12: Rotar IC, Dumitras DE, Popp RA, Petrisor FM, Cotutiu P, Stamatian F, Muresan _x000D_ D. VEGF +936 C/T Genetic Polymorphism in Patients with Cervical Dysplasia. Anal_x000D_ Cell Pathol (Amst). 2016;2016:6074275. Epub 2016 Oct 12. PubMed PMID: 27812483;_x000D_ PubMed Central PMCID: PMC5080462.
    • _x000D_ _x000D_ _x000D_
  • 13: Hu ZQ, Xue H, Long JH, Wang Y, Jia Y, Qiu W, Zhou J, Wen ZY, Yao WJ, Zeng Z. _x000D_ Biophysical Properties and Motility of Human Mature Dendritic Cells Deteriorated _x000D_ by Vascular Endothelial Growth Factor proteins through Cytoskeleton Remodeling. Int J Mol _x000D_ Sci. 2016 Oct 31;17(11). pii: E1756. PubMed PMID: 27809226; PubMed Central PMCID:_x000D_ PMC5133777.
    • _x000D_ _x000D_ _x000D_
  • 14: Camerin GR, Brito AB, Vassallo J, Derchain SF, Lima CS. VEGF gene_x000D_ polymorphisms and outcome of epithelial ovarian cancer patients. Future Oncol._x000D_ 2017 Feb;13(5):409-414. doi: 10.2217/fon-2016-0299. Epub 2016 Oct 26. PubMed_x000D_ PMID: 27780361.
    • _x000D_ _x000D_ _x000D_
  • 15: Lee S, Kang HG, Choi JE, Lee JH, Kang HJ, Baek SA, Lee E, Seok Y, Lee WK, Lee_x000D_ SY, Yoo SS, Lee J, Cha SI, Kim CH, Cho S, Park JY. The Different Effect of VEGF_x000D_ Polymorphisms on the Prognosis of Non-Small Cell Lung Cancer according to Tumor_x000D_ Histology. J Korean Med Sci. 2016 Nov;31(11):1735-1741. doi:_x000D_ 10.3346/jkms.2016.31.11.1735. PubMed PMID: 27709850; PubMed Central PMCID:_x000D_ PMC5056204.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Human VEGF Recombinant Protein”

Your email address will not be published. Required fields are marked *

Related products

Bevacizumab Biosimilar – Anti-VEGF mAb – Research Grade
Biosimilar

Bevacizumab Biosimilar – Anti-VEGF mAb – Research Grade

PX-TA1006 143$
View product
Ranibizumab Biosimilar – Anti-VEGF mAb – Research Grade
Biosimilar

Ranibizumab Biosimilar – Anti-VEGF mAb – Research Grade

PX-TA1008 238$
View product
Aflibercept Biosimilar – Anti-VEGF mAb – Research Grade
Biosimilar

Aflibercept Biosimilar – Anti-VEGF mAb – Research Grade

PX-TA1016 238$
View product
Ramucirumab Biosimilar – Anti-VEGFR-2 mAb – Research Grade
Biosimilar

Ramucirumab Biosimilar – Anti-VEGFR-2 mAb – Research Grade

PX-TA1023 143$
View product
IMC-1C11 Biosimilar – Anti-VEGFA mAb – Research Grade
Biosimilar

IMC-1C11 Biosimilar – Anti-VEGFA mAb – Research Grade

PX-TA1132 238$
View product
Alacizumab Biosimilar – Anti-KDR, VEGFR2, CD309 mAb – Research Grade
Biosimilar

Alacizumab Biosimilar – Anti-KDR, VEGFR2, CD309 mAb – Research Grade

PX-TA1167 238$
View product
Icrucumab Biosimilar – Anti-FLT1, VEGFR-1 mAb – Research Grade
Biosimilar

Icrucumab Biosimilar – Anti-FLT1, VEGFR-1 mAb – Research Grade

PX-TA1257 238$
View product
Vesencumab Biosimilar – Anti-Neuropilin-1, NRP1, VEGF165R extracellular domain mAb – Research Grade
Biosimilar

Vesencumab Biosimilar – Anti-Neuropilin-1, NRP1, VEGF165R extracellular domain mAb – Research Grade

PX-TA1266 238$
View product
Vanucizumab Biosimilar – Anti-ANGPT2, VEGFA, mAb – Research Grade
Biosimilar

Vanucizumab Biosimilar – Anti-ANGPT2, VEGFA, mAb – Research Grade

PX-TA1355 238$
View product
Brolucizumab Biosimilar – Anti-VEGFA mAb – Research Grade
Biosimilar

Brolucizumab Biosimilar – Anti-VEGFA mAb – Research Grade

PX-TA1374 238$
View product
Varisacumab Biosimilar – Anti-VEGFA mAb – Research Grade
Biosimilar

Varisacumab Biosimilar – Anti-VEGFA mAb – Research Grade

PX-TA1458 238$
View product
Faricimab Biosimilar – Anti-ANGPT2, VEGFA mAb – Research Grade
Biosimilar

Faricimab Biosimilar – Anti-ANGPT2, VEGFA mAb – Research Grade

PX-TA1501 238$
View product
Olinvacimab Biosimilar – Anti-KDR, VEGFR2 mAb – Research Grade
Biosimilar

Olinvacimab Biosimilar – Anti-KDR, VEGFR2 mAb – Research Grade

PX-TA1520 238$
View product
Dilpacimab Biosimilar – Anti-DLL4, VEGFA mAb – Research Grade
Biosimilar

Dilpacimab Biosimilar – Anti-DLL4, VEGFA mAb – Research Grade

PX-TA1525 238$
View product

Contact us

Send us a message from the form below

    Cart (0 Items)

    Your cart is currently empty.

    View Products